USFDA completes PAI of Lupin’s Aurangabad plant
The US health regulator has concluded the prior approval inspection (PAI) of Lupin’s Aurangabad manufacturing plant. Lupin has said in a statement that during the...
Tag : Lupin
Lupin Outlook for the Week (July 31, 2017 – Aug 04, 2017)
EquityPandit’s Outlook for Lupin for the week (July 31, 2017 – Aug 04, 2017) : LUPIN: Lupin closed the week on negative note losing...
Lupin Outlook for the Week (July 24, 2017 – July 28, 2017)
EquityPandit’s Outlook for Lupin for the week (July 24, 2017 – July 28, 2017) : LUPIN: Lupin closed the week on positive note...
Lupin Outlook for the Week (July 17, 2017 – July 21, 2017)
EquityPandit’s Outlook for Lupin for the week (July 17, 2017 – July 21, 2017) : LUPIN: Lupin closed the week on positive note...
Lupin receives USFDA approval to market anti-fungal capsules
Lupin has got the approval from the US health regulator for marketing its Flucytosine capsules that are used in treating fungal infections. Lupin has said...
Lupin Outlook for the Week (July 10, 2017 – July 14, 2017)
EquityPandit’s Outlook for Lupin for the week (July 10, 2017 – July 14, 2017) : LUPIN: Lupin closed the week on positive note...
Lupin has launched generic conjuctivitis treatment medicine in US
Lupin the domestic pharma major has launched its generic version of Moxifloxacin Hydrochloride Ophthalmic solution in the US market which is used in treating bacterial...
Lupin Outlook for the Week (July 03, 2017 – July 07, 2017)
EquityPandit’s Outlook for Lupin for the week (July 03, 2017 – July 07, 2017) : LUPIN: Lupin closed the week on absolutely flat...
Lupin Outlook for the Week (June 27, 2017 – June 30, 2017)
EquityPandit’s Outlook for Lupin for the week (June 27, 2017 – June 30, 2017) : LUPIN: Lupin closed the week on negative note...
Lupin Outlook for the Week (June 19, 2017 – June 23, 2017)
EquityPandit’s Outlook for Lupin for the week (June 19, 2017 – June 23, 2017) : LUPIN: Lupin closed the week on negative note...